Global Pediatric Proton Therapy Market & Forecast (10 Countries Market Data), Patients Treated
Buy NowGet 10% Free Customization in this Report
Global Pediatric Proton Therapy Market has potential of more than US$ 700 Million by 2021. Rising pediatric cancer incidence and technological improvement to treat faster per patient will boost the pediatric proton therapy market globally.
United States is the Global Leader in Treating Pediatric Patients with Proton Therapy
USA has the highest pediatric proton therapy market share but in future it will lose its market share, due to competition from Germany, France, United Kingdom and Japan. Proton Therapy is becoming a preferential choice of treatment as its ability to treat pediatric cancer in a more efficient way, compared to traditional radiotherapy. Proton Therapy has achieved importance in such a short duration of time period, due to its technological advancement Like Intensity-Modulated Proton Therapy (IMPT) and Pencil Beam Technology.
United States Age Group of (1-4) has the highest Cancer Evidence in Pediatric Proton Therapy Market
The report captures the USA pediatric proton therapy market data on five age groups (<1) Year, (1-4) Year, (5-9) Year, (10-14) Year, (15-18) Year. In these age groups (1-4) Year has highest market.
Ependymoma Cancerous Tumor holds 15 percent market share in USA Pediatric Proton Therapy Market
The report captures 36 Type of Cancer Market & number of pediatric patients in USA. Ependymoma Cancerous Tumor holds the highest market, among all the other 36 pediatric cancer market.
Germany, United Kingdom and France will drive the Europe Pediatric Proton Therapy Market
Germany holds a significant market share in Global Pediatric Proton Therapy Market. United Kingdom is more concerned about proton therapy especially for pediatric treatment. United Kingdom NHS (National Health Service) used to send massive number of pediatric patients for the proton therapy treatment abroad. Switzerland and France are also developing new proton therapy center. France used to have maximum pediatric proton therapy market share in 2010.
Japan, China & South Korea helping the Proton Therapy Market in Asia to Grow
In Asia, Japan has already established their benchmark for the treatment of pediatric patient with proton therapy. China is more focused toward developing 8 proton therapy centers (Under-construction + Planning Phase) to serve their massive population.
Global Pediatric Proton Therapy Market & Forecast (10 Countries Market Data), Patients Treated is the 20th report published by Renub Research on Proton Therapy Market. This 330 page report with 287 figures and 7 Tables provides 10 Countries: Pediatric Proton Therapy Market, Proton Therapy Patient Numbers, Cancer Type Markets in USA, Technology being used at these Proton Therapy Centers and Reimbursement Policies. The report also studies the Proton Therapy Sales & Forecast of four companies - IBA, Varian Medical Systems, Mitsubishi and Hitachi.
Key Questions Answered in the Report?
• What is the Global Pediatric Proton Therapy Market and its growth potential in Future?
• What is the Number of pediatric patients treated by Proton Beam Therapy worldwide?
• What are the reimbursement policies for Proton Therapy across the world?
• What is the Pediatric Proton Therapy Market in United States and Forecast?
• What is the Number of Pediatric Proton Therapy Patients by age group in United States and Forecast
• What is the Number of Pediatric Proton Therapy Patients by tumor type in United States and Forecast
• What is the Pediatric Proton Therapy Market size in Asia (Japan, China and South Korea) and its growth potential in future?
• What is the Number of Pediatric Proton Therapy patients treated in Asia (Japan, China and South Korea)?
• What is the Pediatric Proton Therapy Market in Europe (Germany, France, Sweden, Switzerland, Czech and United Kingdom) and Forecast?
• What is the Number of Pediatric Proton Therapy Patients in Europe (Germany, France, Sweden, Switzerland, Czech and United Kingdom) and Forecast?
• What Type of Technology is being used at Proton Therapy Centers?
Key Companies Proton Therapy Sales Analysis (2010 – 2021)
1. IBA
2. Varian Medical Systems
3. Mitsubishi
4. Hitachi
Countries Pediatric Proton Therapy Market & Number of Patients studied in the Report
1. United States
2. United Kingdom
3. Switzerland
4. Germany
5. France
6. Sweden
7. Czech Republic
8. Japan
9. Korea
10. China
1. Research Findings
2. Global Pediatric Proton Therapy Number of Patients (Actual & Potential)
2.1 Pediatric Patients Treated with Proton Therapy Actual Numbers & Forecast
2.2 Pediatric Patients with Proton Therapy Potential Numbers & Forecast
3. Global Pediatric Proton Therapy Market (Actual & Potential)
3.1 Pediatric Proton Therapy Market & Forecast
3.2 Pediatric Proton Therapy - Potential Market & Forecast
4. Global Pediatric Proton Therapy Market Share & Forecast
4.1 By Region (Asia, Europe, USA) – Global Pediatric Proton Therapy Market Share
4.2 By Countries – Global Pediatric Proton Therapy Market Share
5. United States Pediatric Proton Therapy Market (Actual & Potential)
5.1 United States Pediatric Proton Therapy Market & Forecast
5.2 United States Potential Pediatric Proton Therapy Market & Forecast
6. USA Pediatric Proton Therapy Market by Age Group
6.1 By Age Group (<1) Year
6.2 By Age Group (1-4) Year
6.3 By Age Group (5-9) Year
6.4 By Age Group (10-14) Year
6.5 By Age Group (15-18) Year
7. USA Pediatric Proton Therapy Patient Number - Actual and Potential
7.1 USA Pediatric Patients Treated with Proton Therapy Numbers & Forecast
7.2 USA Pediatric Patients with Proton Therapy Potential Numbers & Forecast
8. USA Pediatric Proton Therapy Patients Numbers by Age Group
8.1 By Age (<1) Year
8.2 By Age (1- 4) Year
8.3 By Age (5- 9) Year
8.4 By Age (10-14) Year
8.5 By Age (15- 18) Year
9. Tumor Types – USA Pediatrics Proton Therapy Market (2010 – 2021)
9.1 Glioma, Low Grade – Market & Forecast
9.2 Glioma, High Grade – Market & Forecast
9.3 Medulloblastoma – Market & Forecast
9.4 Ependymoma – Market & Forecast
9.5 ATRT – Market & Forecast
9.6 Germinoma, Pure – Market & Forecast
9.7 Germ Cell Tumor – Market & Forecast
9.8 Craniopharyngioma – Market & Forecast
9.9 PNET – Market & Forecast
9.10 Pineoblastoma – Market & Forecast
9.11 Chordoma/Chondrosarcoma – Market & Forecast
9.12 Meningioma – Market & Forecast
9.13 AVM – Market & Forecast
9.14 Adenoma – Market & Forecast
9.15 Choroid Plexus Carcinoma – Market & Forecast
9.16 Retinoblastoma – Market & Forecast
9.17 Osteosarcoma – Market & Forecast
9.18 Ewing Sarcoma – Market & Forecast
9.19 Rhabdomyosarcoma – Market & Forecast
9.20 Other Sarcoma, High Grade – Market & Forecast
9.21 Other Sarcoma, Low Grade – Market & Forecast
9.22 Teratoma – Market & Forecast
9.23 Neuroblastoma – Market & Forecast
9.24 Ganglioglioma – Market & Forecast
9.25 Wilm’s Tumor – Market & Forecast
9.26 Carcinoma (non-CPC) – Market & Forecast
9.27 Lymphoma, Hodgkin’s – Market & Forecast
9.28 Lymphoma, Non-hodgkin’s – Market & Forecast
9.29 Leukemia – Market & Forecast
9.30 Desmoid – Market & Forecast
9.31 Melanoma – Market & Forecast
9.32 Pineal Parenchymal Tumor – Market & Forecast
9.33 Esthesioneuroblastoma – Market & Forecast
9.34 Angiofibroma – Market & Forecast
9.35 Extrarenal Rhabdoid Tumor – Market & Forecast
9.36 Others – Market & Forecast
10. Tumor Types USA Pediatrics Proton Therapy Patients (2010 – 2021)
10.1 Glioma, Low Grade – Patient Numbers & Forecast
10.2 Glioma, High Grade - Patient Numbers & Forecast
10.3 Medulloblastoma - Patient Numbers & Forecast
10.4 Ependymoma - Patient Numbers & Forecast
10.5 ATRT - Patient Numbers & Forecast
10.6 Germinoma, pure - Patient Numbers & Forecast
10.7 Germ Cell Tumor - Patient Numbers & Forecast
10.8 Craniopharyngioma - Patient Numbers & Forecast
10.9 PNET - Patient Numbers & Forecast
10.10 Pineoblastoma - Patient Numbers & Forecast
10.11 Chordoma/Chondrosarcoma - Patient Numbers & Forecast
10.12 Meningioma - Patient Numbers & Forecast
10.13 AVM - Patient Numbers & Forecast
10.14 Adenoma - Patient Numbers & Forecast
10.15 Choroid Plexus Carcinoma - Patient Numbers & Forecast
10.16 Retinoblastoma - Patient Numbers & Forecast
10.17 Osteosarcoma - Patient Numbers & Forecast
10.18 Ewing Sarcoma - Patient Numbers & Forecast
10.19 Rhabdomyosarcoma - Patient Numbers & Forecast
10.20 Other Sarcoma, High Grade - Patient Numbers & Forecast
10.21 Other Sarcoma, Low Grade - Patient Numbers & Forecast
10.22 Teratoma - Patient Numbers & Forecast
10.23 Neuroblastoma - Patient Numbers & Forecast
10.24 Ganglioglioma - Patient Numbers & Forecast
10.25 Wilm’s Tumor - Patient Numbers & Forecast
10.26 Carcinoma (non-CPC) - Patient Numbers & Forecast
10.27 Lymphoma, Hodgkin’s - Patient Numbers & Forecast
10.28 Lymphoma, Non-hodgkin’s - Patient Numbers & Forecast
10.29 Leukemia - Patient Numbers & Forecast
10.30 Desmoid - Patient Numbers & Forecast
10.31 Melanoma - Patient Numbers & Forecast
10.32 Pineal Parenchymal Tumor - Patient Numbers & Forecast
10.33 Esthesioneuroblastoma - Patient Numbers & Forecast
10.34 Angiofibroma - Patient Numbers & Forecast
10.35 Extrarenal Rhabdoid Tumor - Patient Numbers & Forecast
10.36 Others - Patient Numbers & Forecast
11. Europe Pediatric Proton Therapy Market (Actual & Potential)
11.1 Europe Pediatric Proton Therapy Market
11.2 Europe Pediatric Proton Therapy Potential Market
12. Europe Pediatric Proton Therapy Number of Patients (Actual & Potential)
12.1 Europe – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
12.2 Europe – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
13. Europe Pediatric Proton Therapy Market Share by Countries
14. France Pediatric Proton Therapy Market – Actual & Potential Market
14.1 France – Pediatric Proton Therapy Market & Forecast
14.2 France – Potential Pediatric Proton Therapy Market
15. France Pediatric Proton Therapy Patient Number – Actual and Potential
15.1 France – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
15.2 France – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
16. Germany Pediatric Proton Therapy Market – Actual & Potential Market
16.1 Germany – Pediatric Proton Therapy Market & Forecast
16.2 Germany – Potential Pediatric Proton Therapy Market
17. Germany Pediatric Proton Therapy Patient Number – Actual and Potential
17.1 Germany – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
17.2 Germany – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
18. Switzerland Pediatric Proton Therapy Market – Actual & Potential Market
18.1 Switzerland Pediatric Proton Therapy Market & Forecast
18.2 Switzerland – Pediatric Proton Therapy Potential Market & Forecast
19. Switzerland Pediatric Proton Therapy Patient Number – Actual and Potential
19.1 Switzerland – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
19.2 Switzerland – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
20. Sweden Pediatric Proton Therapy Market – Actual & Potential Market
20.1 Sweden - Pediatric Proton Therapy Market & Forecast
20.2 Sweden – Potential Pediatric Proton Therapy Market & Forecast
21. Sweden Pediatric Proton Therapy Patient Number – Actual and Potential
21.1 Sweden – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
21.2 Sweden – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
22. Czech Republic Pediatric Proton Therapy Market – Actual & Potential Market
22.1 Czech Republic Pediatric Proton Therapy Market & Forecast
22.2 Czech Republic Potential Pediatric Proton Therapy Market & Forecast
23. Czech Republic Proton Therapy Patient Number – Actual and Potential
23.1 Czech Republic – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
23.2 Czech Republic – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
24. United Kingdom Pediatric Proton Therapy Market – Actual & Potential Market
24.1 United Kingdom Pediatric Proton Therapy Market & Forecast
24.2 United Kingdom Pediatric Proton therapy Market with NHS Expenditure
24.3 United Kingdom Pediatric Proton Therapy Potential Market & Forecast
25. United Kingdom Pediatric Proton Therapy Patient Number – Actual and Potential
25.1 United Kingdom – Patients Treated with Proton Therapy Numbers & Forecast
25.2 Treatment Patterns of Pediatric Patients with Proton Therapy in United Kingdom and Abroad
25.3 United Kingdom – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
26. Asia Pediatric Proton Therapy Market (Actual & Potential)
26.1 Asia Pediatric Proton Therapy Market & Forecast
26.2 Asia Pediatric Proton Therapy - Potential Market & Forecast
27. Asia Pediatric Proton Therapy Number of Patients (Actual & Potential)
27.1 Asia – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
27.2 Asia – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
28. By Countries – Asia Pediatric Proton Therapy Market Share
29. Japan Pediatric Proton Therapy - Actual & Potential Market
29.1 Japan – Pediatric Proton Therapy Market & Forecast
29.2 Japan – Potential Pediatric Proton Therapy Market & Forecast
30. Japan Pediatric Proton Therapy Patient Number – Actual and Potential
30.1 Japan – Pediatric Patients Treated with Proton Therapy Actual Numbers & Forecast
30.2 Japan – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
31. China Pediatric Proton Therapy Market - Actual & Potential Market
31.1 China – Pediatric Proton Therapy Market & Forecast
31.2 China – Potential Pediatric Proton Therapy Market
32. China Pediatric Proton Therapy Patients Number – Actual and Potential
32.1 China – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
32.2 China – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
33. South Korea Pediatric Proton Therapy Market – Actual & Potential Market
33.1 South Korea – Pediatric Proton Therapy Market & Forecast
33.2 South Korea – Potential Pediatric Proton Therapy Market & Forecast
34. South Korea Pediatric Proton Therapy Patient Number – Actual and Potential
34.1 South Korea – Pediatric Patients Treated with Proton Therapy Numbers & Forecast
34.2 South Korea – Pediatric Patients with Proton Therapy Potential Numbers & Forecast
35. Components of a Standard Proton Therapy Center
35.1 Proton Accelerator
35.1.1 Synchrotrons (example: LLUMC at Loma Linda)
35.1.2 Cyclotrons (example: MGH Boston)
35.1.3 Synchrocyclotrons (examples: Orsay, Uppsala)
35.1.4 H-minus Synchrotrons
35.1.5 Separated Sector Cyclotrons
35.1.6 Super-conducting Cyclotrons
35.1.7 Fast Cycling Synchrotron
35.2 Beam Transport System
35.3 Beam Delivery System
35.3.1 The Passive Scattering Technique
35.3.2 Beam Scanning
35.4 Nozzle
35.4.1 Single Scattering
35.4.2 Double Scattering
35.4.3 Uniform Scanning Nozzle
35.4.4 Pencil Scanning Nozzle
35.5 Treatment Planning System
35.6 Image Viewers
35.7 Patient Positioning System (PPS)
35.8 Human Resource
36. Proton Therapy – Driving Factors
36.1 Technology Advancement
36.2 Rising Prevalence of Pediatric Cancer Globally
37. Proton Therapy – Challenges
37.1 Requires Huge Investment
37.2 Operations Challenges
38. Global Proton Therapy - Company Analysis (2010-2021)
38.1 IBA Proton Therapy
38.1.1 Sales Analysis
38.1.2 IBA List of Proton Therapy Centers
38.2 Varian Medical Systems
38.2.1 Sales Analysis
38.3 Mitsubishi Electric Corporation
38.3.1 Sales Analysis
38.3.2 Mitsubishi List of Proton Therapy Center
38.4 Hitachi
38.4.1 Sales Analysis
38.4.2 Hitachi List of Proton Therapy Center
39. Proton Therapy – Reimbursement Policies
39.1 Proton Therapy Reimbursement Policies for Patients
39.2 Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers
List of Figures
Figure 2‑1: Global – Pediatric Proton Therapy Patients (Number), 2010 – 2016
Figure 2‑2: Global – Forecast for Pediatric Proton Therapy Patients (Number), 2017 – 2021
Figure 2‑3: Global – Potential Pediatric Patient for Proton Therapy (Number), 2010 – 2016
Figure 2‑4: Global – Forecast for Potential Pediatric Patient for Proton Therapy (Number), 2017 – 2021
Figure 3‑1: Global – Pediatric Proton Therapy Market (Million US$), 2010 – 2016
Figure 3‑2: Global – Forecast for Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 3‑3: Global – Potential Pediatric Proton Therapy Market (Million US$), 2010 – 2016
Figure 3‑4: Global – Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 4‑1: Global – Pediatric Proton Beam Therapy Market Share (Percent) by Region, 2010 – 2016
Figure 4‑2: Global – Forecast for Pediatric Proton Beam Therapy Market Share (Percent) by Region, 2017 – 2021
Figure 5‑1: United States – Pediatric Proton Therapy Market (Million US$), 2010 – 2016
Figure 5‑2: United States – Forecast for Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 5‑3: United States – Potential Pediatric Proton Therapy Market (Million US$), 2010 – 2016
Figure 5‑4: United States – Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 6‑1: United States – Pediatric Proton Therapy Market by Age Group (<1) (Million US$), 2010 – 2016
Figure 6‑2: United States – Forecast for Pediatric Proton Therapy Market by Age Group (<1) (Million US$), 2017 – 2021
Figure 6‑3: United States – Pediatric Proton Therapy Market by Age Group (1-4) (Million US$), 2010 – 2016
Figure 6‑4: United States – Forecast for Pediatric Proton Therapy Market by Age Group (1-4) (Million US$), 2017 – 2021
Figure 6‑5: United States – Pediatric Proton Therapy Market by Age Group (5-9) (Million US$), 2010 – 2016
Figure 6‑6: United States – Forecast for Pediatric Proton Therapy Market by Age Group (5-9) (Million US$), 2017 – 2021
Figure 6‑7: United States – Pediatric Proton Therapy Market by Age Group (10-14) (Million US$), 2010 – 2016
Figure 6‑8: United States – Forecast for Pediatric Proton Therapy Market by Age Group (10-14) (Million US$), 2017 – 2021
Figure 6‑9: United States – Pediatric Proton Therapy Market by Age Group (15-18) (Million US$), 2010 – 2016
Figure 6‑10: United States – Forecast for Pediatric Proton Therapy Market by Age Group (15-18) (Million US$), 2017 – 2021
Figure 7‑1: United States – Pediatric Proton Therapy Patients (Number), 2010 – 2016
Figure 7‑2: United States – Forecast for Pediatric Proton Therapy Patients (Number), 2017 – 2021
Figure 7‑3: United States – Potential Pediatric Proton Therapy Patients (Number), 2010 – 2016
Figure 7‑4: United States – Forecast for Potential Pediatric Proton Therapy Patients (Number), 2017 – 2021
Figure 8‑1: United States – Pediatric Proton Therapy Patients by Age Group (<1) (Number), 2010 – 2016
Figure 8‑2: United States – Forecast for Pediatric Proton Therapy Patients by Age Group (<1) (Number), 2017 – 2021
Figure 8‑3: United States – Pediatric Proton Therapy Patients by Age Group (1-4) (Number), 2010 – 2016
Figure 8‑4: United States – Forecast for Pediatric Proton Therapy Patients by Age Group (1-4) (Number), 2017 – 2021
Figure 8‑5: United States – Pediatric Proton Therapy Patients by Age Group (5-9) (Number), 2010 – 2016
Figure 8‑6: United States – Forecast for Pediatric Proton Therapy Patients by Age Group (5-9) (Number), 2017 – 2021
Figure 8‑7: United States – Pediatric Proton Therapy Patients by Age Group (10-14) (Number), 2010 – 2016
Figure 8‑8: United States – Forecast for Pediatric Proton Therapy Patients by Age Group (10-14) (Number), 2017 – 2021
Figure 8‑9: United States – Pediatric Proton Therapy Patients by Age Group (15-18) (Number), 2010 – 2016
Figure 8‑10: United States – Forecast for Pediatric Proton Therapy Patients by Age Group (15-18) (Number), 2017 – 2021
Figure 9‑1: United States – Glioma, Low Grade Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑2: United States – Forecast for Glioma, Low Grade Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑3: United States – Glioma, High Grade Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑4: United States – Forecast for Glioma, High Grade Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑5: United States – Medulloblastoma Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑6: United States – Forecast for Medulloblastoma Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑7: United States – Ependymoma Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑8: United States – Forecast for Ependymoma Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑9: United States – ATRT Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑10: United States – Forecast for ATRT Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑11: United States – Germinoma, Pure Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑12: United States – Forecast for Germinoma, Pure Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑13: United States – Germ Cell Tumor Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑14: United States – Forecast for Germ Cell Tumor Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑15: United States – Craniopharyngioma Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑16: United States – Forecast for Craniopharyngioma Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑17: United States – PNET Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑18: United States – Forecast for PNET Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑19: United States – Pineoblastoma Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑20: United States – Forecast for Pineoblastoma Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑21: United States – Chordoma Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑22: United States – Forecast for Chordoma Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑23: United States – Meningioma Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑24: United States – Forecast for Meningioma Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑25: United States – AVM Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑26: United States – Forecast for AVM Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑27: United States – Adenoma Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑28: United States – Forecast for Adenoma Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑29: United States – Choroid Plexus Carcinoma Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑30: United States – Forecast for Choroid Plexus Carcinoma Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑31: United States – Retinoblastoma Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑32: United States – Forecast for Retinoblastoma Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑33: United States – Osteosarcoma Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑34: United States – Forecast for Osteosarcoma Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑35: United States – Ewing Sarcoma Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑36: United States – Forecast for Ewing sarcoma Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑37: United States – Rhabdomyosarcoma Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑38: United States – Forecast for Rhabdomyosarcoma Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑39: United States – Other Sarcoma, High Grade Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑40: United States – Forecast for Other Sarcoma, High Grade Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑41: United States – Other Sarcoma, Low Grade Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑42: United States – Forecast for Other Sarcoma, Low Grade Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑43: United States – Teratoma Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑44: United States – Forecast for Teratoma Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑45: United States – Neuroblastoma Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑46: United States – Forecast for Neuroblastoma Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑47: United States – Ganglioglioma Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑48: United States – forecast for Ganglioglioma Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑49: United States – Wilms tumor Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑50: United States – Forecast for Wilms tumor Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑51: United States – Carcinoma (non-CPC) Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑52: United States – Forecast for Carcinoma (non-CPC) Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑53: United States – Hodgkin's Lymphoma Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑54: United States – Forecast for Hodgkin's Lymphoma Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑55: United States – Non-Hodgkin Lymphoma Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑56: United States – Forecast for Non-Hodgkin Lymphoma Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑57: United States – Leukemia Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑58: United States – Forecast for Leukemia Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑59: United States – Desmoid Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑60: United States – Forecast for Desmoid Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑61: United States – Melanoma Pediatric Proton Therapy Market (Thousand US$), 2010 – 2016
Figure 9‑62: United States – Forecast for Melanoma Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑63: United States – Pediatric Proton Therapy Market for Pineal Parenchymal Tumor (Thousand US$), 2010 – 2016
Figure 9‑64: United States – Forecast for Pediatric Proton Therapy Market for Pineal Parenchymal Tumor (Thousand US$), 2017 – 2021
Figure 9‑65: United States – Pediatric Proton Therapy Market for Esthesioneuroblastoma (Thousand US$), 2010 – 2016
Figure 9‑66: United States – Forecast for Esthesioneuroblastoma Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑67: United States – Pediatric Proton Therapy Market for Angiofibroma (Thousand US$), 2010 – 2016
Figure 9‑68: United States – Forecast for Angiofibroma Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 9‑69: United States – Pediatric Proton Therapy Market for Extrarenal Rhabdoid Tumor (Thousand US$), 2010 – 2016
Figure 9‑70: United States – Forecast for Pediatric Proton Therapy Market by Extrarenal Rhabdoid Tumor (Thousand US$), 2017 – 2021
Figure 9‑71: United States – Pediatric Proton Therapy Market for Others (Thousand US$), 2010 – 2016
Figure 9‑72: United States – Forecast for Others Pediatric Proton Therapy Market (Thousand US$), 2017 – 2021
Figure 10‑1: United States – Pediatric Proton Therapy Patients by Glioma, Low Grade (Number), 2010 – 2016
Figure 10‑2: United States – Forecast for Pediatric Proton Therapy Patients by Glioma, Low Grade (Number), 2017 – 2021
Figure 10‑3: United States – Pediatric Proton Therapy Patients by Glioma, High Grade (Number), 2010 – 2016
Figure 10‑4: United States – Forecast for Pediatric Proton Therapy Patients by Glioma, High Grade (Number), 2017 – 2021
Figure 10‑5: United States – Pediatric Proton Therapy Patients by Medulloblastoma (Number), 2010 – 2016
Figure 10‑6: United States – Forecast for Pediatric Proton Therapy Patients by Medulloblastoma (Number), 2017 – 2021
Figure 10‑7: United States – Pediatric Proton Therapy Patients by Ependymoma (Number), 2010 – 2016
Figure 10‑8: United States – Forecast for Pediatric Proton Therapy Patients by Ependymoma (Number), 2017 – 2021
Figure 10‑9: United States – Pediatric Proton Therapy Patients by ATRT (Number), 2010 – 2016
Figure 10‑10: United States – Forecast for Pediatric Proton Therapy Patients by ATRT (Number), 2017 – 2021
Figure 10‑11: United States – Pediatric Proton Therapy Patients by Germinoma, pure (Number), 2010 – 2016
Figure 10‑12: United States – Forecast for Pediatric Proton Therapy Patients by Germinoma, pure (Number), 2017 – 2021
Figure 10‑13: United States – Pediatric Proton Therapy Patients by Germ Cell Tumor (Number), 2010 – 2016
Figure 10‑14: United States – Forecast for Pediatric Proton Therapy Patients by Germ Cell Tumor (Number), 2017 – 2021
Figure 10‑15: United States – Pediatric Proton Therapy Patients by Craniopharyngioma (Number), 2010 – 2016
Figure 10‑16: United States – Forecast for Pediatric Proton Therapy Patients by Craniopharyngioma (Number), 2017 – 2021
Figure 10‑17: United States – Pediatric Proton Therapy Patients by PNET (Number), 2010 – 2016
Figure 10‑18: United States – Forecast for Pediatric Proton Therapy Patients by PNET (Number), 2017 – 2021
Figure 10‑19: United States – Pediatric Proton Therapy Patients by Pineoblastoma (Number), 2010 – 2016
Figure 10‑20: United States – Forecast for Pediatric Proton Therapy Patients by Pineoblastoma (Number), 2017 – 2021
Figure 10‑21: United States – Pediatric Proton Therapy Patients by Chordoma/Chondrosarcoma (Number), 2010 – 2016
Figure 10‑22: United States – Forecast for Pediatric Proton Therapy Patients by Chordoma/Chondrosarcoma (Number), 2017 – 2021
Figure 10‑23: United States – Pediatric Proton Therapy Patients by Meningioma (Number), 2010 – 2016
Figure 10‑24: United States – Forecast for Pediatric Proton Therapy Patients by Meningioma (Number), 2017 – 2021
Figure 10‑25: United States – Pediatric Proton Therapy Patients by AVM (Number), 2010 – 2016
Figure 10‑26: United States – Forecast for Pediatric Proton Therapy Patients by AVM (Number), 2017 – 2021
Figure 10‑27: United States – Pediatric Proton Therapy Patients by Adenoma (Number), 2010 – 2016
Figure 10‑28: United States – Forecast for Pediatric Proton Therapy Patients by Adenoma (Number), 2017 – 2021
Figure 10‑29: United States – Pediatric Proton Therapy Patients by Choroid Plexus Carcinoma (Number), 2010 – 2016
Figure 10‑30: United States – Forecast for Pediatric Proton Therapy Patients by Choroid Plexus Carcinoma (Number), 2017 – 2021
Figure 10‑31: United States – Pediatric Proton Therapy Patients by Retinoblastoma (Number), 2010 – 2016
Figure 10‑32: United States – Forecast for Pediatric Proton Therapy Patients by Retinoblastoma (Number), 2017 – 2021
Figure 10‑33: United States – Pediatric Proton Therapy Patients by Osteosarcoma (Number), 2010 – 2016
Figure 10‑34: United States – Forecast for Pediatric Proton Therapy Patients by Osteosarcoma (Number), 2017 – 2021
Figure 10‑35: United States – Pediatric Proton Therapy Patients by Ewing Sarcoma (Number), 2010 – 2016
Figure 10‑36: United States – Forecast for Pediatric Proton Therapy Patients by Ewing Sarcoma (Number), 2017 – 2021
Figure 10‑37: United States – Pediatric Proton Therapy Patients by Rhabdomyosarcoma (Number), 2010 – 2016
Figure 10‑38: United States – Forecast Pediatric Proton Therapy Patients by Rhabdomyosarcoma (Number), 2017 – 2021
Figure 10‑39: United States – Pediatric Proton Therapy Patients by Other Sarcoma, High Grade (Number), 2010 – 2016
Figure 10‑40: United States – Forecast for Pediatric Proton Therapy Patients by Other Sarcoma, High Grade (Number), 2017 – 2021
Figure 10‑41: United States – Pediatric Proton Therapy Patients by Other Sarcoma, Low Grade (Number), 2010 – 2016
Figure 10‑42: United States – Forecast for Pediatric Proton Therapy Patients by Other Sarcoma, Low Grade (Number), 2017 – 2021
Figure 10‑43: United States – Pediatric Proton Therapy Patients by Teratoma (Number), 2010 – 2016
Figure 10‑44: United States – Forecast for Pediatric Proton Therapy Patients by Teratoma (Number), 2017 – 2021
Figure 10‑45: United States – Pediatric Proton Therapy Patients by Neuroblastoma (Number), 2010 – 2016
Figure 10‑46: United States – Forecast for Pediatric Proton Therapy Patients by Neuroblastoma (Number), 2017 – 2021
Figure 10‑47: United States – Pediatric Proton Therapy Patients by Ganglioglioma (Number), 2010 – 2016
Figure 10‑48: United States – Forecast for Pediatric Proton Therapy Patients by Ganglioglioma (Number), 2017 – 2021
Figure 10‑49: United States – Pediatric Proton Therapy Patients by Wilm’s Tumor (Number), 2010 – 2016
Figure 10‑50: United States – Forecast for Pediatric Proton Therapy Patients by Wilm’s Tumor (Number), 2017 – 2021
Figure 10‑51: United States – Pediatric Proton Therapy Patients by Carcinoma (non-CPC) (Number), 2010 – 2016
Figure 10‑52: United States – Forecast for Pediatric Proton Therapy Patients by Carcinoma (non-CPC) (Number), 2017 – 2021
Figure 10‑53: United States – Pediatric Proton Therapy Patients by Lymphoma, Hodgkin’s (Number), 2010 – 2016
Figure 10‑54: United States – Forecast for Pediatric Proton Therapy Patients by Lymphoma, Hodgkin’s (Number), 2017 – 2021
Figure 10‑55: United States – Pediatric Proton Therapy Patients by Lymphoma, Non-hodgkin’s (Number), 2010 – 2016
Figure 10‑56: United States – Forecast for Pediatric Proton Therapy Patients by Lymphoma, Non-hodgkin’s (Number), 2010 – 2016
Figure 10‑57: United States – Pediatric Proton Therapy Patients by Leukemia (Number), 2010 – 2016
Figure 10‑58: United States – Forecast for Pediatric Proton Therapy Patients by Leukemia (Number), 2017 – 2021
Figure 10‑59: United States – Pediatric Proton Therapy Patients by Desmoid (Number), 2010 – 2016
Figure 10‑60: United States – Forecast for Pediatric Proton Therapy Patients by Desmoid (Number), 2017 – 2021
Figure 10‑61: United States – Pediatric Proton Therapy Patients by Melanoma (Number), 2010 – 2016
Figure 10‑62: United States – Forecast for Pediatric Proton Therapy Patients by Melanoma (Number), 2017 – 2021
Figure 10‑63: United States – Pediatric Proton Therapy Patients by Pineal Parenchymal Tumor (Number), 2010 – 2016
Figure 10‑64: United States – Forecast for Pediatric Proton Therapy Patients by Pineal Parenchymal Tumor (Number), 2017 – 2021
Figure 10‑65: United States – Pediatric Proton Therapy Patients by Esthesioneuroblastoma (Number), 2010 – 2016
Figure 10‑66: United States – Forecast for Pediatric Proton Therapy Patients by Esthesioneuroblastoma (Number), 2017 – 2021
Figure 10‑67: United States – Pediatric Proton Therapy Patients by Angiofibroma (Number), 2010 – 2016
Figure 10‑68: United States – Forecast for Pediatric Proton Therapy Patients by Angiofibroma (Number), 2017 – 2021
Figure 10‑69: United States – Pediatric Proton Therapy Patients by Extrarenal Rhabdoid Tumor (Number), 2010 – 2016
Figure 10‑70: United States – Forecast for Pediatric Proton Therapy Patients by Extrarenal Rhabdoid Tumor (Number), 2017 – 2021
Figure 10‑71: United States – Pediatric Proton Therapy Patients by Others (Number), 2010 – 2016
Figure 10‑72: United States – Forecast for Pediatric Proton Therapy Patients by Others (Number), 2017 – 2021
Figure 11‑1: Europe – Pediatric Proton Therapy Market (Million US$), 2010 – 2016
Figure 11‑2: Europe – Forecast for Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 11‑3: Europe – Potential Pediatric Proton Therapy Market (Million US$), 2010 – 2016
Figure 11‑4: Europe – Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 12‑1: Europe – Pediatric Proton Therapy Patients (Number), 2010 – 2016
Figure 12‑2: Europe – Forecast for Pediatric Proton Therapy Patients (Number), 2017 – 2021
Figure 12‑3: Europe – Potential Pediatric Patient for Proton Therapy (Number), 2010 – 2016
Figure 12‑4: Europe – Forecast for Potential Pediatric Patient for Proton Therapy (Number), 2017 – 2021
Figure 13‑1: Europe – Pediatric Proton Therapy Market Share (Percent) by Countries, 2010 – 2016
Figure 13‑2: Europe – Forecast for Pediatric Proton Therapy Market Share (Percent) by Countries, 2017 – 2021
Figure 14‑1: France – Pediatric Proton Therapy Market (Million US$), 2010 – 2016
Figure 14‑2: France – Forecast for Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 14‑3: France – Potential Pediatric Proton Therapy Market (Million US$), 2010 – 2016
Figure 14‑4: France – Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 15‑1: France – Pediatric Proton Therapy Patients (Number), 2010 – 2016
Figure 15‑2: France – Forecast for Pediatric Proton Therapy Patients (Number), 2017 – 2021
Figure 15‑3: France – Potential Pediatric Patient for Proton Therapy (Number), 2010 – 2016
Figure 15‑4: France – Forecast for Potential Pediatric Proton Therapy Patient (Number), 2017 – 2021
Figure 16‑1: Germany – Pediatric Proton Therapy Market (Million US$), 2010 – 2016
Figure 16‑2: Germany – Forecast for Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 16‑3: Germany – Potential Pediatric Proton Therapy Market (Million US$), 2010 – 2016
Figure 16‑4: Germany – Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 17‑1: Germany – Pediatric Proton Therapy Patients (Number), 2010 – 2016
Figure 17‑2: Germany – Forecast for Pediatric Proton Therapy Patients (Number), 2017 – 2021
Figure 17‑3: Germany – Potential Pediatric Patient for Proton Therapy (Number), 2010 – 2016
Figure 17‑4: Germany – Forecast for Potential Pediatric Proton Therapy Patient (Number), 2017 – 2021
Figure 18‑1: Switzerland – Pediatric Proton Therapy Market (Million US$), 2010 – 2016
Figure 18‑2: Switzerland – Forecast for Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 18‑3: Switzerland – Potential Pediatric Proton Therapy Market (Million US$), 2010 – 2016
Figure 18‑4: Switzerland – Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 19‑1: Switzerland – Pediatric Proton Therapy Patients (Number), 2010 – 2016
Figure 19‑2: Switzerland – Forecast for Pediatric Proton Therapy Patients (Number), 2017 – 2021
Figure 19‑3: Switzerland – Potential Pediatric Patient for Proton Therapy (Number), 2010 – 2016
Figure 19‑4: Switzerland – Forecast for Potential Pediatric Proton Therapy Patient (Number), 2017 – 2021
Figure 20‑1: Sweden – Pediatric Proton Therapy Market (Million US$), 2011 – 2016
Figure 20‑2: Sweden – Forecast for Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 20‑3: Sweden – Potential Pediatric Proton Therapy Market (Million US$), 2010 – 2016
Figure 20‑4: Sweden – Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 21‑1: Sweden – Pediatric Proton Therapy Patients (Number), 2011 – 2016
Figure 21‑2: Sweden – Pediatric Proton Therapy Patients (Number), 2017 – 2021
Figure 21‑3: Sweden – Potential Pediatric Patient for Proton Therapy (Number), 2010 – 2016
Figure 21‑4: Sweden – Forecast for Potential Pediatric Proton Therapy Patient (Number), 2017 – 2021
Figure 22‑1: Czech Republic – Pediatric Proton Therapy Market (Million US$), 2013 – 2016
Figure 22‑2: Czech Republic – Forecast for Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 22‑3: Czech Republic – Potential Pediatric Proton Therapy Market (Million US$), 2010 – 2016
Figure 22‑4: Czech Republic – Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 23‑1: Czech Republic – Pediatric Proton Therapy Patients (Number), 2013 – 2016
Figure 23‑2: Czech Republic – Forecast for Pediatric Proton Therapy Patients (Number), 2017 – 2021
Figure 23‑3: Czech Republic – Potential Pediatric Proton Therapy Patients (Number), 2010 – 2016
Figure 23‑4: Czech Republic – Forecast for Potential Pediatric Proton Therapy Patients (Number), 2017 – 2021
Figure 24‑1: United Kingdom – Pediatric Proton Therapy Market (Million US$), 2010 – 2016
Figure 24‑2: United Kingdom – Forecast for Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 24‑3: United Kingdom – Pediatric Proton Therapy Market and NHS Expenditure (Million US$), 2010 – 2016
Figure 24‑4: United Kingdom – Forecast for Pediatric Proton Therapy Market and NHS Expenditure (Million US$), 2010 – 2016
Figure 24‑5: United Kingdom – Potential Pediatric Proton Therapy Market (Million US$), 2010 – 2016
Figure 24‑6: United Kingdom – Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 25‑1: United Kingdom – Pediatric Proton Therapy Patients (Number), 2010 – 2016
Figure 25‑2: United Kingdom – Forecast for Pediatric Proton Therapy Patients (Number), 2017 – 2021
Figure 25‑3: United Kingdom – Forecast for Proportion of Pediatric Proton Therapy Patients in U.K and Abroad (Number), 2017 – 2021
Figure 25‑4: United Kingdom – Potential Pediatric Proton Therapy Patients (Number), 2010 – 2016
Figure 25‑5: United Kingdom – Forecast for Potential Pediatric Proton Therapy Patients (Number), 2017 – 2021
Figure 26‑1: Asia – Pediatric Proton Therapy Market (Million US$), 2010 – 2016
Figure 26‑2: Asia – Forecast for Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 26‑3: Asia – Potential Pediatric Proton Therapy Market (Million US$), 2010 – 2016
Figure 26‑4: Asia – Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 27‑1: Asia – Pediatric Proton Therapy Patients (Number), 2010 – 2016
Figure 27‑2: Asia – Forecast for Pediatric Proton Therapy Patients (Number), 2017 – 2021
Figure 27‑3: Asia – Potential Pediatric Patient for Proton Therapy (Number), 2010 – 2016
Figure 27‑4: Asia – Forecast for Potential Pediatric Patient for Proton Therapy (Number), 2017 – 2021
Figure 28‑1: Asia – Pediatric Proton Therapy Market Share (Percent) by Countries, 2010 – 2016
Figure 28‑2: Asia – Forecast for Pediatric Proton Therapy Market Share (Percent) by Countries, 2017 – 2021
Figure 29‑1: Japan – Pediatric Proton Therapy Market (Million US$), 2010 – 2016
Figure 29‑2: Japan – Forecast for Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 29‑3: Japan – Potential Pediatric Proton Therapy Market (Million US$), 2010 – 2016
Figure 29‑4: Japan – Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 30‑1: Japan – Pediatric Proton Therapy Patients (Number), 2010 – 2016
Figure 30‑2: Japan – Forecast for Pediatric Proton Therapy Patients (Number), 2017 – 2021
Figure 30‑3: Japan – Potential Pediatric Patient for Proton Therapy (Number), 2010 – 2016
Figure 30‑4: Japan – Forecast for Proton Therapy Potential Pediatric Patient (Number), 2017 – 2021
Figure 31‑1: China – Pediatric Proton Therapy Market (Million US$), 2014 – 2016
Figure 31‑2: China – Forecast for Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 31‑3: China – Potential Pediatric Proton Therapy Market (Million US$), 2010 – 2016
Figure 31‑4: China – Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 32‑1: China – Pediatric Proton Therapy Patients (Number), 2014 – 2016
Figure 32‑2: China – Forecast for Pediatric Proton Therapy Patients (Number), 2017 – 2021
Figure 32‑3: China – Potential Pediatric Patient for Proton Therapy (Number), 2010 – 2016
Figure 32‑4: China – Forecast for Potential Pediatric Patient with Proton Therapy (Number), 2017 – 2021
Figure 33‑1: South Korea – Pediatric Proton Therapy Market (Million US$), 2010 – 2016
Figure 33‑2: South Korea – Forecast for Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 33‑3: South Korea – Potential Pediatric Proton Therapy Market (Million US$), 2010 – 2016
Figure 33‑4: South Korea – Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 – 2021
Figure 34‑1: South Korea – Pediatric Proton Therapy Patients (Number), 2010 – 2016
Figure 34‑2: South Korea – Forecast for Pediatric Proton Therapy Patients (Number), 2017 – 2021
Figure 34‑3: South Korea – Potential Pediatric Patient for Proton Therapy (Number), 2010 – 2016
Figure 34‑4: South Korea – Forecast Potential Pediatric Patient with Proton Therapy (Number), 2017 – 2021
Figure 36‑1: Global – Pediatric Patient Diagnosed With Cancer (Number), 2010 – 2016
Figure 36‑2: Global – Forecast for Pediatric Patient Diagnosed With Cancer (Number), 2017 – 2022
Figure 38‑1: Global – IBA Proton Therapy Sales (Million US$), 2010 – 2016
Figure 38‑2: Global – Forecast for IBA Proton Therapy Sales (Million US$), 2017 – 2021
Figure 38‑3: Global – Varian Medical Systems Oncology Systems Sales (Million US$), 2010 – 2016
Figure 38‑4: Global – Forecast for Varian Medical Systems Oncology Systems Sales (Million US$), 2017 – 2021
Figure 38‑5: Global – Mitsubishi Electric Corporation Energy and Electric Systems Sales (Million US$), 2010 – 2016
Figure 38‑6: Global – Forecast for Mitsubishi Electric Corporation Energy and Electric Systems Sales (Million US$), 2017 – 2021
Figure 38‑7: Global – Hitachi Electronic Systems and Equipment Sales (Million US$), 2010 – 2016
Figure 38‑8: Global – Forecast for Hitachi Electronic Systems and Equipment Sales (Million US$), 2017 – 2021
List of Tables
Table 3‑1: Global – IBA Multiple Room Proton Therapy Center
Table 4‑1: Global – Pediatric Proton Beam Therapy Market Share (Percent) by Countries, 2010 – 2016
Table 4‑2: Global – Forecast for Pediatric Proton Beam Therapy Market Share (Percent) by Countries, 2017 – 2021
Table 24‑1: United Kingdom – Under-Construction Proton Therapy Center with Operational Launch Year
Table 38‑1: Global – IBA Proton Therapy Centers in Operational and Under-Construction Phase
Table 38‑2: Global – Mitsubishi Proton Therapy Centers in Operational and Under-Construction Phase
Table 38‑3: Global – Hitachi Proton Therapy Centers in Operational and Under-Construction Phase
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com